CRV
Listed as “3T Biosciences”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Company website description: We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the treatment of solid…
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “3T Biosciences”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.